Wednesday, June 10, 2026

Patent intelligence · WO

WO 0250105

COMPOSES

expired A61K 38/ 00 A IA61K 48/ 00 A IA61P 9/ 00 A IA61P 17/ 00 A I
Status expired
Years to expiry 0
Applicant portfolio 25
Patent details — WO 0250105
Jurisdiction
WO
Status
expired
Grant date
Jun 27, 2002
Expiration
Jun 22, 2022
CPC classes
A61K 38/ 00 A I, A61K 48/ 00 A I, A61P 9/ 00 A I, A61P 17/ 00 A I
View on Google Patents ↗

Quick answer

WO 0250105 (COMPOSES) is held by SMITHKLINE BEECHAM CORP [US]. Status: expired. Granted Jun 27, 2002. Expires Jun 22, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
CPC classes
A61K 38/ 00 A I, A61K 48/ 00 A I, A61P 9/ 00 A I, A61P 17/ 00 A I, A61P 25/ 00 A I, A61P 35/ 00 A I

More from SMITHKLINE BEECHAM CORP [US]

Related pharmaceutical patents in our USPTO index.

  1. SA 92120308

    تركيبة للاستخدام الموضعي topical composition

    BEECHAM GROUP PLC [GB] · Expires Jun 10, 2025

    expired
  2. AT E269330

    CHEMISCHE VERBINDUNGEN

    BEECHAM GROUP PLC [GB] · Expires Jul 10, 2024

    expired
  3. EP 1425277

    HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG

    SMITHKLINE BEECHAM PLC [GB] · Expires Jun 4, 2024

    expired
  4. SA 91110341

    مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus

    BEECHAM GROUP PLC [GB] · Expires May 20, 2024

    expired
  5. HU P0302480

    PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

    SMITHKLINE BEECHAM PLC [GB] · Expires Dec 24, 2023

    expired
  6. AT E245157

    3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

    BEECHAM GROUP PLC [GB] · Expires Aug 10, 2023

    expired
  7. HK 1004528

    Dentifrice compositions

    BEECHAM GROUP PLC [GB] · Expires Jul 5, 2023

    expired
  8. HU P0204410

    PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE

    SMITHKLINE BEECHAM PLC [GB] · Expires May 23, 2023

    expired

Frequently asked questions

What is US patent 0250105?

WO 0250105 (COMPOSES) is held by SMITHKLINE BEECHAM CORP [US]. Status: expired. Granted Jun 27, 2002. Expires Jun 22, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.

Who owns WO 0250105?

SMITHKLINE BEECHAM CORP [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.

When does WO 0250105 expire?

Our index shows an expiration date of Jun 22, 2022 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.